Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01316289 · ClinicalTrials.gov registry record
Pilon Fracture Reduction and Functional Outcome
A clinical trial of Pilon Fracture of Tibia, sponsored by AO Clinical Investigation and Publishing Documentation.
- Completed
- Registry status
- 117
- Enrollment target
- 9
- Study locations
NCT01316289: Completed study of Pilon Fracture of Tibia, sponsored by AO Clinical Investigation and Publishing Documentation.
NCT01316289 is a study of Pilon Fracture of Tibia that has completed, run by AO Clinical Investigation and Publishing Documentation. The registered enrollment target is 117 participants. The trial reports 9 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01316289, a study of Pilon Fracture of Tibia, has completed, sponsored by AO Clinical Investigation and Publishing Documentation.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
- 9
- Study locations
Study Summary
This prospective case series will essentially examine the influence of reduction quality on the primary functional outcome (as assessed using the FAAM) of patients with pilon fractures treated with plate fixation. The plates used in this trial can be chosen according to the preferences of the surgeon.
Primary Outcome
The most important predictors of functional outcome after pilon fracture will be identified by evaluating the influence of radiologically assessed parameters of reduction quality and other factors (age, high/low energy trauma, AO fracture type, open/closed fracture, delay between trauma and definitive fracture fixation) on the FAAM. In parallel, the radiological parameters will also be validated with respect to their reliability.
Conditions Studied
Study Locations (9)
Other
- Medical University Innsbruck - Innsbruck
- Cantonal Hospital Graubuenden - Chur
- Cantonal Hospital Luzern - Lucerne
- Cantonal Hospital Winterthur - Winterthur
Indiana
- Indiana Orthopaedic Hospital - Indianapolis
Minnesota
- University of Minnesota - Saint Paul
Mississippi
- University of Mississippi Medical Center - Jackson
Washington
- Harborview Medical Center - Seattle
CEP
- Universidade de São Paulo - Faculdade de Medicina - São Paulo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2011-11 |
| Est. Completion | 2017-03 |
What the finished NCT01316289 record still lists
NCT01316289 is an observational study that tracks outcomes without assigning an intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Pilon Fracture of Tibia appearing as the primary indexed condition, and to 0 interventions.
NCT01316289 lists 9 locations in 6 states (Other, Indiana, Minnesota).
Frequently Asked Questions
What is clinical trial NCT01316289 about?
NCT01316289 is a clinical study titled "Pilon Fracture Reduction and Functional Outcome". This prospective case series will essentially examine the influence of reduction quality on the primary functional outcome (as assessed using the FAAM) of patients with pilon fractures treated with plate fixation. The plates used in this trial can be chosen according to the preferences of the surge...
What is the current status of trial NCT01316289?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2011-11. Estimated completion is 2017-03.
What conditions does trial NCT01316289 study?
This clinical trial studies the following conditions: Pilon Fracture of Tibia.
Who is sponsoring clinical trial NCT01316289?
This trial is sponsored by AO Clinical Investigation and Publishing Documentation, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01316289 being conducted?
This trial has 9 study locations across Indiana, Minnesota, Mississippi, Washington, CEP. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia